Device Trial Radar · NCT00546598
Post-approval Study of the DURALOC® Option Ceramic-on-Ceramic Hip Prosthesis System
Last checked: Nov 20, 2026Latest source record: Nov 30, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
106
Actual
Start
Jan 1, 2006
Primary completion
Apr 1, 2014
Study completion Apr 1, 2014
Sponsor
- Lead sponsor
- DePuy OrthopaedicsPublic (JNJ)
- Sponsor type
- Industry
- First posted
- Oct 19, 2007
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 21 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is being conducted to gather medium and long-term information regarding the performance and safety of the commercially available DURALOC® Option Ceramic-on-Ceramic Hip Prosthesis System.
Conditions
- Non-inflammatory Joint Disease
- Osteoarthritis
- Avascular Necrosis
- Congenital Hip Dysplasia
- Post-traumatic Arthritis
Interventions
Total hip replacement/arthroplastyDevice
Hip replacement
Primary outcomes
What the sponsor says the trial is designed to measure.
- SurvivorshipTime frame: 5 years
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Northside Hospital
Atlanta, Georgia
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.